CoChat

Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis

Open access
Wheeler, Eleanor, Leong, Aaron, Liu, Ching-Ti, Hivert, Marie-France, Strawbridge, Rona J., Podmore, Clara, Li, Man, Yao, Jie, Sim, Xueling, Hong, Jaeyoung, Chu, Audrey Y., Zhang, Weihua, Wang, Xu, Chen, Peng, Maruthur, Nisa M., Porneala, Bianca C., Sharp, Stephen J., Jia, Yucheng, Kabagambe, Edmond K., Chang, Li-Ching, Chen, Wei-Min, Elks, Cathy E., Evans, Daniel S., Fan, Qiao, Giulianini, Franco, Go, Min Jin, Hottenga, Jouke-Jan, Hu, Yao, Jackson, Anne U., Kanoni, Stavroula, Kim, Young Jin, Kleber, Marcus E., Ladenvall, Claes, Lecoeur, Cecile, Lim, Sing-Hui, Lu, Yingchang, Mahajan, Anubha, Marzi, Carola, Nalls, Mike A., Navarro, Pau, Nolte, Ilja M., Rose, Lynda M., Rybin, Denis V., Sanna, Serena, Shi, Yuan, Stram, Daniel O., Takeuchi, Fumihiko, Tan, Shu Pei, van der Most, Peter J., Van Vliet-Ostaptchouk, Jana V., Wong, Andrew, Yengo, Loic, Zhao, Wanting, Goel, Anuj, Martinez Larrad, Maria Teresa, Radke, Dörte, Salo, Perttu, Tanaka, Toshiko, van Iperen, Erik P. A., Abecasis, Goncalo, Afaq, Saima, Alizadeh, Behrooz Z., Bertoni, Alain G., Bonnefond, Amelie, Böttcher, Yvonne, Bottinger, Erwin P., Campbell, Harry, Carlson, Olga D., Chen, Chien-Hsiun, Cho, Yoon Shin, Garvey, W. Timothy, Gieger, Christian, Goodarzi, Mark O., Grallert, Harald, Hamsten, Anders, Hartman, Catharina A., Herder, Christian, Hsiung, Chao Agnes, Huang, Jie, Igase, Michiya, Isono, Masato, Katsuya, Tomohiro, Khor, Chiea-Chuen, Kiess, Wieland, Kohara, Katsuhiko, Kovacs, Peter, Lee, Juyoung, Lee, Wen-Jane, Lehne, Benjamin, Li, Huaixing, Liu, Jianjun, Lobbens, Stephane, Luan, Jian'an, Lyssenko, Valeriya, Meitinger, Thomas, Miki, Tetsuro, Miljkovic, Iva, Moon, Sanghoon, Mulas, Antonella, Müller, Gabriele, Müller-Nurasyid, Martina, Nagaraja, Ramaiah, Nauck, Matthias, Pankow, James S., Polasek, Ozren, Prokopenko, Inga, Ramos, Paula S., Rasmussen-Torvik, Laura, Rathmann, Wolfgang, Rich, Stephen S., Robertson, Neil R., Roden, Michael, Roussel, Ronan, Rudan, Igor, Scott, Robert A., Scott, William R., Sennblad, Bengt, Siscovick, David S., Strauch, Konstantin, Sun, Liang, Swertz, Morris, Tajuddin, Salman M., Taylor, Kent D., Teo, Yik-Ying, Tham, Yih Chung, Tönjes, Anke, Wareham, Nicholas J., Willemsen, Gonneke, Wilsgaard, Tom, Hingorani, Aroon D., EPIC-CVD Consortium, EPIC-InterAct Consortium, Lifelines Cohort Study, Egan, Josephine, Ferrucci, Luigi, Hovingh, G. Kees, Jula, Antti, Kivimaki, Mika, Kumari, Meena, Njølstad, Inger, Palmer, Colin N. A., Serrano Ríos, Manuel, Stumvoll, Michael, Watkins, Hugh, Aung, Tin, Blüher, Matthias, Boehnke, Michael, Boomsma, Dorret I., Bornstein, Stefan R., Chambers, John C., Chasman, Daniel I., Chen, Yii-Der Ida, Chen, Yduan-Tsong, Cheng, Ching-Yu, Cucca, Francesco, de Geus, Eco J. C., Deloukas, Panos, Evans, Michele K., Fornage, Myriam, Friedlander, Yechiel, Froguel, Philippe, Groop, Leif, Gross, Myron D., Harris, Tamara B., Hayward, Caroline, Heng, Chew-Kiat, Ingelsson, Erik, Kato, Norihiro, Kim, Bong-Jo, Koh, Woon-Puay, Kooner, Jaspal S., Körner, Antje, Kuh, Diana, Kuusisto, Johanna, Laakso, Markku, Lin, Xu, Liu, Yongmei, Loos, Ruth J. F., Magnusson, Patrik K. E., März, Winfried, McCarthy, Mark I., Oldehinkel, Albertine J., Ong, Ken K., Pedersen, Nancy L., Pereira, Mark A., Peters, Annette, Ridker, Paul M., Sabanayagam, Charumathi, Sale, Michele, Saleheen, Danish, Saltevo, Juha, Schwarz, Peter EH., Sheu, Wayne H. H., Snieder, Harold, Spector, Timothy D., Tabara, Yasuharu, Tuomilehto, Jaakko, van Dam, Rob M., Wilson, James G., Wilson, James F., Wolffenbuttel, Bruce H. R., Wong, Tien Yin, Wu, Jer-Yuarn, Yuan, Jian-Min, Zonderman, Alan B., Soranzo, Nicole, Guo, Xiuqing, Roberts, David J., Florez, Jose C., Sladek, Robert, Dupuis, Josée, Morris, Andrew P., Tai, E-Shyong, Selvin, Elizabeth, Rotter, Jerome I., Langenberg, Claudia, Barroso, Inês, Meigs, James B. · 2017 · PLOS Medicine

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Glycated hemoglobin (HbA1c) is used to diagnose type 2 diabetes (T2D) and assess glycemic control in patients with diabetes. Previous genome-wide association studies (GWAS) have identified 18 HbA1c-associated genetic variants. These variants proved to be classifiable by their likely biological action as erythrocytic (also associated with erythrocyte traits) or glycemic (associated with other glucose-related traits). In this study, we tested the hypotheses that, in a very large scale GWAS, we would identify more genetic variants associated with HbA1c and that HbA1c variants implicated in erythrocytic biology would affect the diagnostic accuracy of HbA1c. We therefore expanded the number of HbA1c-associated loci and tested the effect of genetic risk-scores comprised of erythrocytic or glycemic variants on incident diabetes prediction and on prevalent diabetes screening performance. Throughout this multiancestry study, we kept a focus on interancestry differences in HbA1c genetics performance that might influence race-ancestry differences in health outcomes. METHODS & FINDINGS: Using genome-wide association meta-analyses in up to 159,940 individuals from 82 cohorts of European, African, East Asian, and South Asian ancestry, we identified 60 common genetic variants associated with HbA1c. We classified variants as implicated in glycemic, erythrocytic, or unclassified biology and tested whether additive genetic scores of erythrocytic variants (GS-E) or glycemic variants (GS-G) were associated with higher T2D incidence in multiethnic longitudinal cohorts (N = 33,241). Nineteen glycemic and 22 erythrocytic variants were associated with HbA1c at genome-wide significance. GS-G was associated with higher T2D risk (incidence OR = 1.05, 95% CI 1.04-1.06, per HbA1c-raising allele, p = 3 × 10-29); whereas GS-E was not (OR = 1.00, 95% CI 0.99-1.01, p = 0.60). In Europeans and Asians, erythrocytic variants in aggregate had only modest effects on the diagnostic accuracy of HbA1c. Yet, in African Americans, the X-linked G6PD G202A variant (T-allele frequency 11%) was associated with an absolute decrease in HbA1c of 0.81%-units (95% CI 0.66-0.96) per allele in hemizygous men, and 0.68%-units (95% CI 0.38-0.97) in homozygous women. The G6PD variant may cause approximately 2% (N = 0.65 million, 95% CI 0.55-0.74) of African American adults with T2D to remain undiagnosed when screened with HbA1c. Limitations include the smaller sample sizes for non-European ancestries and the inability to classify approximately one-third of the variants. Further studies in large multiethnic cohorts with HbA1c, glycemic, and erythrocytic traits are required to better determine the biological action of the unclassified variants. CONCLUSIONS: As G6PD deficiency can be clinically silent until illness strikes, we recommend investigation of the possible benefits of screening for the G6PD genotype along with using HbA1c to diagnose T2D in populations of African ancestry or groups where G6PD deficiency is common. Screening with direct glucose measurements, or genetically-informed HbA1c diagnostic thresholds in people with G6PD deficiency, may be required to avoid missed or delayed diagnoses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002383

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Manhattan plot of HbA1c associated variants. Manhattan plot of the transethnic meta-analysis results in MANTRA. The dashed grey line indicates log10BF = 6. Grey and green points denote known/novel loci, respectively. The lead HbA1c-associated variants identified through the ancestry-specific/transethnic analyses are circled in purple (the G6PD variant was not included in the MANTRA analysis, but the locus on the X-chromosome is indicated in the figure). Lines joining the plot & SNP number denote known loci (black), novel loci (green), and loci with a secondary distinct signal (red). MANTRA, Meta-Analysis of Transethnic Association.
Fig 1 Manhattan plot of HbA1c associated variants. Manhattan plot of the transethnic meta-analysis results in MANTRA. The dashed grey line indicates log10BF = 6. Grey and green points denote known/novel loci, respectively. The lead HbA1c-associated variants identified through the ancestry-specific/transethnic analyses are circled in purple (the G6PD variant was not included in the MANTRA analysis, but the locus on the X-chromosome is indicated in the figure). Lines joining the plot & SNP number denote known loci (black), novel loci (green), and loci with a secondary distinct signal (red). MANTRA, Meta-Analysis of Transethnic Association.CC0 · PubMed Central
Fig 2 T2D prediction, glycemic genetic score. Forest plot of association between glycemic genetic score with incident T2D over a decade-long follow-up period, by ancestry. MESA (European and Asian ancestry) and the G6PD variant (rs1050828) in ARIC (European and African American) were not included in the discovery GWAS analysis. Effect estimates were combined in a fixed effects meta-analysis. Overall effect estimate: 1.05, 95% CI 1.04–1.06, p = 2.5 × 10−29. ARIC, Atherosclerosis Risk in Communities Study; ES, Effect Size; FHS, Framingham Heart Study; GWAS, genome-wide association study; G6PD, glucose-6-phosphate dehydrogenase; I-Squared, Higgin's I-squared statistic, a measure of heterogeneity; MESA, Multiethnic Study of Atherosclerosis; SCHS, Singapore Chinese Health Study; T2D, type 2 diabetes.
Fig 2 T2D prediction, glycemic genetic score. Forest plot of association between glycemic genetic score with incident T2D over a decade-long follow-up period, by ancestry. MESA (European and Asian ancestry) and the G6PD variant (rs1050828) in ARIC (European and African American) were not included in the discovery GWAS analysis. Effect estimates were combined in a fixed effects meta-analysis. Overall effect estimate: 1.05, 95% CI 1.04–1.06, p = 2.5 × 10−29. ARIC, Atherosclerosis Risk in Communities Study; ES, Effect Size; FHS, Framingham Heart Study; GWAS, genome-wide association study; G6PD, glucose-6-phosphate dehydrogenase; I-Squared, Higgin's I-squared statistic, a measure of heterogeneity; MESA, Multiethnic Study of Atherosclerosis; SCHS, Singapore Chinese Health Study; T2D, type 2 diabetes.CC0 · PubMed Central
Fig 3 T2D prediction, erythrocytic genetic score. Forest plot of association between erythrocytic genetic score with incident T2D over a decade-long follow-up period, by ancestry. MESA (European and Asian ancestry) and the G6PD variant (rs1050828) in ARIC (European and African American) were not included in the discovery GWAS analysis. Effect estimates were combined in a fixed effects meta-analysis. Overall effect estimate: 1.00, 95% CI 0.99–1.01, p = 0.60. ARIC, Atherosclerosis Risk in Communities Study; ES, Effect Size, FHS, Framingham Heart Study; GWAS, genome-wide association study; G6PD, glucose-6-phosphate dehydrogenase; I-Squared, Higgin's I-squared statistic, a measure of heterogeneity; MESA, Multiethnic Study of Atherosclerosis; SCHS, Singapore Chinese Health Study; T2D, type 2 diabetes.
Fig 3 T2D prediction, erythrocytic genetic score. Forest plot of association between erythrocytic genetic score with incident T2D over a decade-long follow-up period, by ancestry. MESA (European and Asian ancestry) and the G6PD variant (rs1050828) in ARIC (European and African American) were not included in the discovery GWAS analysis. Effect estimates were combined in a fixed effects meta-analysis. Overall effect estimate: 1.00, 95% CI 0.99–1.01, p = 0.60. ARIC, Atherosclerosis Risk in Communities Study; ES, Effect Size, FHS, Framingham Heart Study; GWAS, genome-wide association study; G6PD, glucose-6-phosphate dehydrogenase; I-Squared, Higgin's I-squared statistic, a measure of heterogeneity; MESA, Multiethnic Study of Atherosclerosis; SCHS, Singapore Chinese Health Study; T2D, type 2 diabetes.CC0 · PubMed Central
Fig 4 T2D prediction, erythrocytic genetic score adjusted for HbA1c as a binary variable. Forest plot of association between erythrocytic genetic score with incident T2D over a decade-long follow-up period adjusted for HbA1c as a binary variable (≥5.7% versus <5.7%), by ancestry. HbA1c at baseline was not available in SCHS and was excluded from the meta-analysis. MESA (European and Asian ancestry) and the G6PD variant (rs1050828) in ARIC (European and African American) were not included in the discovery GWAS analysis. Effect estimates were combined in a fixed effects meta-analysis. Overall effect estimate: 0.95, 95% CI 0.94–0.96, p = 3.3 × 10−16. ARIC, Atherosclerosis Risk in Communities Study; ES, Effect Size; GWAS, genome-wide association study; FHS, Framingham Heart Study; G6PD, glucose-6-phosphate dehydrogenase; HbA1c, glycated hemoglobin; I-Squared, Higgin's I-squared statistic, a measure of heterogeneity; MESA, multiethnic study of atherosclerosis; SCHS, Singapore Chinese Health Study; T2D, type 2 diabetes.
Fig 4 T2D prediction, erythrocytic genetic score adjusted for HbA1c as a binary variable. Forest plot of association between erythrocytic genetic score with incident T2D over a decade-long follow-up period adjusted for HbA1c as a binary variable (≥5.7% versus <5.7%), by ancestry. HbA1c at baseline was not available in SCHS and was excluded from the meta-analysis. MESA (European and Asian ancestry) and the G6PD variant (rs1050828) in ARIC (European and African American) were not included in the discovery GWAS analysis. Effect estimates were combined in a fixed effects meta-analysis. Overall effect estimate: 0.95, 95% CI 0.94–0.96, p = 3.3 × 10−16. ARIC, Atherosclerosis Risk in Communities Study; ES, Effect Size; GWAS, genome-wide association study; FHS, Framingham Heart Study; G6PD, glucose-6-phosphate dehydrogenase; HbA1c, glycated hemoglobin; I-Squared, Higgin's I-squared statistic, a measure of heterogeneity; MESA, multiethnic study of atherosclerosis; SCHS, Singapore Chinese Health Study; T2D, type 2 diabetes.CC0 · PubMed Central
Fig 5 Mean HbA1c of individuals at the bottom 5% and top 5% of the distribution of ancestry-specific genetic scores and rs1050828 by genotype. The difference in measured HbA1c of individuals at the bottom 5% and top 5% of the distribution of an ancestry-specific additive GS composed of all 60 variants (GS-Total), and the equivalent calculation for an ancestry-specific GS composed of up to 20 erythrocytic variants (GS-E). Far right of the figure shows the mean HbA1c by genotype for chromosome X rs1050828. AA men, African American men; AA women, African American women; HbA1c, glycated hemoglobin; GS, genetic scores.
Fig 5 Mean HbA1c of individuals at the bottom 5% and top 5% of the distribution of ancestry-specific genetic scores and rs1050828 by genotype. The difference in measured HbA1c of individuals at the bottom 5% and top 5% of the distribution of an ancestry-specific additive GS composed of all 60 variants (GS-Total), and the equivalent calculation for an ancestry-specific GS composed of up to 20 erythrocytic variants (GS-E). Far right of the figure shows the mean HbA1c by genotype for chromosome X rs1050828. AA men, African American men; AA women, African American women; HbA1c, glycated hemoglobin; GS, genetic scores.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 415

Metadata

Authors
Wheeler, E., Leong, A., Liu, C.-T., Hivert, M.-F., Strawbridge, R. J., Podmore, C., Li, M., Yao, J., Sim, X., Hong, J., Chu, A. Y., Zhang, W., Wang, X., Chen, P., Maruthur, N. M., Porneala, B. C., Sharp, S. J., Jia, Y., Kabagambe, E. K., Chang, L.-C., Chen, W.-M., Elks, C. E., Evans, D. S., Fan, Q., Giulianini, F., Go, M. J., Hottenga, J.-J., Hu, Y., Jackson, A. U., Kanoni, S., Kim, Y. J., Kleber, M. E., Ladenvall, C., Lecoeur, C., Lim, S.-H., Lu, Y., Mahajan, A., Marzi, C., Nalls, M. A., Navarro, P., Nolte, I. M., Rose, L. M., Rybin, D. V., Sanna, S., Shi, Y., Stram, D. O., Takeuchi, F., Tan, S. P., van der Most, P. J., Van Vliet-Ostaptchouk, J. V., Wong, A., Yengo, L., Zhao, W., Goel, A., Martinez Larrad, M. T., Radke, D., Salo, P., Tanaka, T., van Iperen, E. P. A., Abecasis, G., Afaq, S., Alizadeh, B. Z., Bertoni, A. G., Bonnefond, A., Böttcher, Y., Bottinger, E. P., Campbell, H., Carlson, O. D., Chen, C.-H., Cho, Y. S., Garvey, W. T., Gieger, C., Goodarzi, M. O., Grallert, H., Hamsten, A., Hartman, C. A., Herder, C., Hsiung, C. A., Huang, J., Igase, M., Isono, M., Katsuya, T., Khor, C.-C., Kiess, W., Kohara, K., Kovacs, P., Lee, J., Lee, W.-J., Lehne, B., Li, H., Liu, J., Lobbens, S., Luan, J., Lyssenko, V., Meitinger, T., Miki, T., Miljkovic, I., Moon, S., Mulas, A., Müller, G., Müller-Nurasyid, M., Nagaraja, R., Nauck, M., Pankow, J. S., Polasek, O., Prokopenko, I., Ramos, P. S., Rasmussen-Torvik, L., Rathmann, W., Rich, S. S., Robertson, N. R., Roden, M., Roussel, R., Rudan, I., Scott, R. A., Scott, W. R., Sennblad, B., Siscovick, D. S., Strauch, K., Sun, L., Swertz, M., Tajuddin, S. M., Taylor, K. D., Teo, Y.-Y., Tham, Y. C., Tönjes, A., Wareham, N. J., Willemsen, G., Wilsgaard, T., Hingorani, A. D., EPIC-CVD Consortium, EPIC-InterAct Consortium, Study, L. C., Egan, J., Ferrucci, L., Hovingh, G. K., Jula, A., Kivimaki, M., Kumari, M., Njølstad, I., Palmer, C. N. A., Serrano Ríos, M., Stumvoll, M., Watkins, H., Aung, T., Blüher, M., Boehnke, M., Boomsma, D. I., Bornstein, S. R., Chambers, J. C., Chasman, D. I., Chen, Y.-D. I., Chen, Y.-T., Cheng, C.-Y., Cucca, F., de Geus, E. J. C., Deloukas, P., Evans, M. K., Fornage, M., Friedlander, Y., Froguel, P., Groop, L., Gross, M. D., Harris, T. B., Hayward, C., Heng, C.-K., Ingelsson, E., Kato, N., Kim, B.-J., Koh, W.-P., Kooner, J. S., Körner, A., Kuh, D., Kuusisto, J., Laakso, M., Lin, X., Liu, Y., Loos, R. J. F., Magnusson, P. K. E., März, W., McCarthy, M. I., Oldehinkel, A. J., Ong, K. K., Pedersen, N. L., Pereira, M. A., Peters, A., Ridker, P. M., Sabanayagam, C., Sale, M., Saleheen, D., Saltevo, J., Schwarz, P. E., Sheu, W. H. H., Snieder, H., Spector, T. D., Tabara, Y., Tuomilehto, J., van Dam, R. M., Wilson, J. G., Wilson, J. F., Wolffenbuttel, B. H. R., Wong, T. Y., Wu, J.-Y., Yuan, J.-M., Zonderman, A. B., Soranzo, N., Guo, X., Roberts, D. J., Florez, J. C., Sladek, R., Dupuis, J., Morris, A. P., Tai, E.-S., Selvin, E., Rotter, J. I., Langenberg, C., Barroso, I., & Meigs, J. B.
Affiliations
  • Wellcome Sanger Institute (GB)
  • Harvard University (US)
  • Boston University (US)
  • Karolinska University Hospital (SE)
  • University of Cambridge (GB)
  • Johns Hopkins University (US)
  • The Lundquist Institute (US)
  • National University of Singapore (SG)
  • Brigham and Women's Hospital (US)
  • Ealing Hospital NHS Trust (GB)
  • National Institutes of Health (US)
  • Massachusetts General Hospital (US)
  • Vanderbilt University Medical Center (US)
  • Institute of Biomedical Sciences, Academia Sinica (TW)
  • University of Virginia (US)
  • AstraZeneca (United Kingdom) (GB)
  • California Pacific Medical Center (US)
  • Duke-NUS Medical School (SG)
  • Korea National Institute of Health (KR)
  • Vrije Universiteit Amsterdam (NL)
  • Chinese Academy of Sciences (CN)
  • University of Michigan (US)
  • Queen Mary University of London (GB)
  • Heidelberg University (DE)
  • Uppsala University (SE)
  • Singapore Eye Research Institute (SG)
  • Icahn School of Medicine at Mount Sinai (US)
  • Centre for Human Genetics (GB)
  • Helmholtz Munich (DE)
  • Western General Hospital (GB)
  • University Medical Center Groningen (NL)
  • Institute of Genetic and Biomedical Research (IT)
  • University of Southern California (US)
  • National Center for Global Health and Medicine (JP)
  • MRC Unit for Lifelong Health and Ageing (GB)
  • Universitätsmedizin Greifswald (DE)
  • University of Helsinki (FI)
  • National Institute on Aging (US)
  • Imperial College London (GB)
  • Wake Forest University Health Sciences (US)
  • IFB Adiposity Diseases (DE)
  • University of Edinburgh (GB)
  • China Medical University (TW)
  • Hallym University (KR)
  • University of Alabama at Birmingham (US)
  • Cedars-Sinai Medical Center (US)
  • Deutsches Diabetes-Zentrum e.V. (DE)
  • The Ohio State University Wexner Medical Center (US)
  • Boston VA Research Institute (US)
  • Ehime University (JP)
  • The University of Osaka (JP)
  • Agency for Science, Technology and Research (SG)
  • University Hospital Leipzig (DE)
  • Taichung Veterans General Hospital (TW)
  • Lund University (SE)
  • University of Pittsburgh (US)
  • University Hospital Carl Gustav Carus (DE)
  • University of Minnesota (US)
  • Medical University of South Carolina (US)
  • German Center for Diabetes Research (DE)
  • Düsseldorf University Hospital (DE)
  • Inserm (FR)
  • New York Academy of Medicine (US)
  • Leipzig University (DE)
  • UiT The Arctic University of Norway (NO)
  • University College London (GB)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Finnish Institute for Health and Welfare (FI)
  • Ninewells Hospital (GB)
  • Imperial College Healthcare NHS Trust (GB)
  • Broad Institute (US)
  • University of Sassari (IT)
  • Hadassah Medical Center (IL)
  • Centre National de la Recherche Scientifique (FR)
  • University of Eastern Finland (FI)
  • Karolinska Institutet (SE)
  • Medical University of Graz (AT)
  • Central Finland Health Care District (FI)
  • Universität für Weiterbildung Krems (AT)
  • NHS Blood and Transplant (GB)
Corresponding author
  • Barroso, Inês
  • Meigs, James B.
ORCID
Venue
PLOS Medicine
Published
2017-09-12
Volume
14
Issue
9
Pages
e1002383
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2755166087
Cited by
408
References
44
Citations by year
2026: 21 · 2025: 26 · 2024: 39 · 2023: 44 · 2022: 45 · 2021: 68 · 2020: 63 · 2019: 58 · 2018: 35 · 2017: 9
FWCI
5.84
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, public-domain)
  • Open Access at Essex (University of Essex) (acceptedVersion)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, public-domain)
  • IRIS (submittedVersion, public-domain)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, public-domain)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • National University of Singapore (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion, public-domain)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
  • Lund University Publications (Lund University) (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • Site cant be reached (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
  • VU Research Portal (submittedVersion, other-oa)
  • SERVAL (Université de Lausanne) (submittedVersion, public-domain)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, public-domain)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Apollo (public-domain)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Michael J. Fox Foundation for Parkinson's Research
  • Amgen
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • NHS Blood and Transplant
  • Regeneron Pharmaceuticals
  • Incyte
  • National Institute for Health and Care Research (NF-SI-0515-10091, NF-SI-0611-10099)
  • British Heart Foundation (RG/10/12/28456, RG/14/5/30893)
  • Kidney Research UK (SP/LOLIPOP/2016)
  • Imperial College London
  • University of Oxford
  • National University of Singapore
  • Institut National de la Santé et de la Recherche Médicale (U1018)
  • Novo Nordisk
  • Centre National de la Recherche Scientifique
  • Universität Leipzig
  • National Institutes of Health
  • Centers for Disease Control and Prevention
  • Medical Research Council (MR/K013351/1, MR/K002414/1, MC_UU_12015/2, MC_UU_12015/1)
  • Japan Society for the Promotion of Science (17H04123)
  • National Heart, Lung, and Blood Institute
  • National Cancer Institute (R01CA144034, R01CA080205, UM1CA182876)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
HbA1c, type 2 diabetes, polygenic risk score, diabetes diagnosis, diabetes screening, diagnostic accuracy, ancestry differences, African Americans
MeSH terms
Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Phenotype, Risk, Genetic Variation, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. https://app.cochat.ai/papers/10.1371/journal.pmed.1002383
The paper
Wheeler, E., Leong, A., Liu, C.-T., Hivert, M.-F., Strawbridge, R. J., Podmore, C., Li, M., Yao, J., Sim, X., Hong, J., Chu, A. Y., Zhang, W., Wang, X., Chen, P., Maruthur, N. M., Porneala, B. C., Sharp, S. J., Jia, Y., Kabagambe, E. K., . . . Meigs, J. B. (2017). Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002383

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.